ExL Pharma's European Medical Science Liaison Conference Brochure, October, London

2,244 views

Published on

Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and advisors are critical to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace.

ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the European MSL & Medical/Scientific Advisor Best Practices conference was born.

We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole.

We look forward to greeting you in London!

Published in: Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,244
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
37
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

ExL Pharma's European Medical Science Liaison Conference Brochure, October, London

  1. 1. REGISTER bY 17 SEPTEMbER FOR REDUcED PRIcING Medical/Scientific Advisor PROUDLY PRESENTS and Medical Science Liaison Best Practices Bringing Maximum Value to the KOL, Company and Industry 28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON FEATURED SESSIONS INCLUDE: Distinguished Speaking Faculty DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SA Exploring Similarities and Differences in Job Titles, Descriptions and Joins Us From: Daily Activities of Medical Science Liaisons, Medical Advisors, and Scientific Advisors across Companies and Countries AMGEN Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global ARNOLD & PORTER Medical Affairs, UCB PHARMA, Belgium BAYER Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom BRISTOL-MYERS SQUIBB INVESTIGATOR INITIATED TRIALS (IITs) BRITISH PHARMACOPOEIA Outlining Best Practices for How MSLs and Advisors Can Best Support COMMISSION the Successful Execution of IITs across the EU FELTER CONSULTING LTD Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom FORMER GENENTECH KEY OPINION LEADER INITIATION AND DEVELOPMENT GLAXOSMITHKLINE Effectively Managing Relationships to Meet the Needs and Objectives LILLY of the KOL and the Company PFIZER Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France SANOFI-AVENTIS cAREER DEVELOPMENT UCB Identifying Different Opportunities Available to Individuals with AND MORE! MSL/Advisor Experience, Education Levels and Skills Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States The Only Event Led by, and Designed for, European Pharmaceutical, Biotech and Medical Device Advisors and MSLs! To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl
  2. 2. Medical/Scientific Advisor and Medical Science Liaison Best Practices 28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON WHo SHoUlD AttenD? Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, Professionals from Pharmaceutical, critique and communicate comprehensive scientific information related to a company’s Biotechnology and Medical Device products. While differences in job titles, backgrounds and day-to-day activities can vary across companies with responsibilities in the companies and regions, MSLs and Advisors are essential to improving understanding amongst following areas: internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help Departments/titles train the sales force, and develop relationships with key opinion leaders, among other activities. • Medical Science Liaisons (MSLS, MLs) MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely • Medical Advisors competitive European marketplace. • Scientific Advisors ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, • Medical Managers with seven highly successful and valuable MSL events taking place throughout America over a five • Medical Scientists year period. These conferences continue to attract more and more industry professionals, and have • Medical Affairs solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical • Scientific Affairs Affairs professionals. From the US-based events, a need was assessed for a similar conference • Regional Medical Education Officers to take place in Europe. Thus, the Medical/Scientific Advisor and Medical Science Liaison Best • Medical Communications Practices conference was born. • Clinical Trial Liaisons We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the • Clinical Research industry to gather to share successful strategies for both field-based and office-based activities. • Medical Education Through the provision of case studies and educational presentations led by experienced industry • Clinical/Outcomes Liaisons professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain • Clinical Investigators take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole. • KOL Development • Business Intelligence We look forward to greeting you in London! • Regulatory Affairs • Marketing Sincerely, this conference is also of interest to: • Software and Technology Companies • Staffing Agencies/Recruiters Lindsay Slater Kristen Hunter • Law Firms Conference Director Team Leader, Production • Consultants European Scientific/Medical Advisor ExL Pharma and MSL Best Practices VENUE INFORMATION Ambassadors Bloomsbury 12 Upper Woburn PlaceLondon, UKWC1H 0HX t +44 (0)20 7693 5400 f +44 (0)20 7388 9930 Ambassadors Bloomsbury is a stylish, contemporary hotel, which prides itself on exceptional standards of customer service. New rooms designed for comfort and style. Visionary conference suites. Cutting edge restaurant and bar. Located just five minutes walk from both Euston and King’s Cross St Pancras stations (the Eurostar termi- nal), Ambassadors Bloomsbury is ideally located for both business trips and short leisure breaks. Please contact the hotel directly at +44 (0)20 7693 5400 to book your room. Please mention ExL Pharma and the conference name to take advantage of the discount. You must book your room by 8th October 2010 to be eligible for the discounted rate. Please book your room early as the rooms available at this rate are limited and review your hotel confirmation to ensure that you received the ExL group rate.
  3. 3. Thursday, 28 October PRE-CONFERENCE WORKSHOP Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom 8:00 · REGISTRATION AND BREAKFAST FOR WORKSHOP PARTICIPANTS 14:00 · INVESTIGATOR INITIATED TRIALS (IITs) Outlining Best Practices for How MSLs and Advisors Can Best 9:00 · PRE-CONFERENCE WORKSHOP: REGULATORY OVERVIEW Support the Successful Execution of IITs across the EU Understanding Requirements and Ensuring Compliant • Providing insight on study ideas and protocols External and Internal Communications while Working • Assisting with the internal approval process for investigators who in a Complex International Environment propose study ideas • Helping to ensure adherence to study timelines and the meeting MSLs and MAs/SAs must take great care in knowing and complying of milestones with the rules, legislation and codes of practice that are relevant to • Fostering the relationship between the investigator and the their roles, so that they do not put themselves, their companies and sponsoring company patients at any undue risk. They must be aware of the boundaries of their positions, especially when interacting with thought leaders in the Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom field as well as with internal commercial teams. The regulations can be complicated to decipher and apply, and can differ significantly across 14:45 NETWORKING AND REFRESHMENT BREAK countries throughout the EU. In this workshop, gain practical and relevant information on: 15:15 · BRAND DEVELOPMENT AND APPROVAL • Exploring similarities and differences in rules related to industry- Collaborating with Marketing and Sales to Foster Brand healthcare provider interactions within different EU nations Strategy, Ensure Compliant Promotional Materials, and • Examining the major regulations and guidance that MSLs must Achieve Corporate Objectives follow in Europe, including an in-depth discussion of the ABPI • Informing the planning and development of branded materials Code of Practice for the Pharmaceutical Industry in the UK • Reviewing promotional pieces for clinical content and • Compliantly communicating with internal sales and marketing compliance with relevant Codes of Practice and regulations before colleagues approving their print and distribution • Developing SOPs within your department to support transpar • Providing clear and meaningful training to internal teams on ency and compliance scientific concepts related to company products • Do’s and don’ts of responding to requests for off-licence informtion • Ensuring transparency and quality of cross-functional exchanges • Outlining the potential consequences of noncompliance for enhanced information sharing and ultimate achievement of • Anticipating the future of increased regulation throughout the EU business goals Vanessa Young, UK/ROI Medical Liaison Manager, LILLY, United Kingdom Dr. Christian Felter, Director, FELTER CONSULTING LTD, United Kingdom Dr. Lincoln Tsang, Partner, ARNOLD & PORTER LLP; Nonexecutive Member, Regulatory Oversight Committee, HEALTH PROTECTION AGENCY; 16:00 · KEY OPINION LEADER INITIATION AND DEVELOPMENT COUNCIL MEMBER, SCHOOL OF PHARMACY, UNIVERSITY OF LON- Effectively Managing Relationships to Meet the DON; Commissioner, BRITISH PHARMACOPOEIA COMMISSION, United Needs and Objectives of the KOL and the Company Kingdom • Developing a strategy for initiating contact with a new KOL – how 10:30 30-MINUTE NETWORKING & REFRESHMENT BREAK to establish credibility and rapport • Strengthening communication skills to highlight therapeutic area 12:00 WORKSHOP CONCLUDES expertise and support relationship building LUNCHEON FOR WORKSHOP PARTICIPANTS • Discussing variations of KOL preferences for information exchange and how to accordingly tailor communication MAIN CONFERENCE BEGINS · DAY ONE • Gathering insights from the field to guide future business decisions Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, 13:00 Chairperson’s Welcome and Opening Remarks BRISTOL-MYERS SQUIBB, France Dr. Alan Yong, Medical Affairs Manager Oncology, GLAXOSMITHKLINE, United Kingdom 16:45 13:15 · DEFINING AND EVALUATING THE ROLE OF THE MSL, MA and SA Roundtable Sessions with Attendees from the 3rd Exploring Similarities and Differences in Job Titles, European Investigator-Initiated Trials Conference: Descriptions and Daily Activities of Medical Science 1 Advisory Board Management: What are best practices for Liaisons, Medical Advisors, and Scientific Advisors supporting, designing and delivering presentations at advisory across Companies and Countries boards? • What nomenclature is most prevalent and accurate to describe 2 Resource Maximisation: How can teams eliminate waste and field-based versus office-based medical affairs experts? implement changes as budgets continue shrink? • Outlining the core objectives of professionals in the above stated 3 Small Company Challenges: How can MSLs and Advisors best positions and how their activities differ manage unique challenges that coincide with working at a • What different educational backgrounds are most commonly smaller company? associated and necessary for each role? 4 Team Management: What criteria should determine how MSLs/ • Describing short-term and long-term goals and responsibilities Advisors are deployed and how can management support the goals of the individual team member, the department and the Marc Van Melckenbeke, Senior Global Director Medical Communication & company? Coordination, Global Medical Affairs, UCB PHARMA, Belgium
  4. 4. Conference Agenda 5 Team Characteristics: What value do different educational 11:00 · CORPORATE BUSINESS OBJECTIVES degrees, professional background and skills bring and how should Aligning the Activities and Goals of Field Based Teams for this impact recruitment decisions? Strengthened Corporate Sustainability 6 Pharmacovigilance: How can MSLs/Advisors most effectively support drug safety? • Examining the disconnect between field based medical and corporate initiatives 17:45 CLOSE OF DAY ONE • Acquiring and synthesizing field insights to drive clinical and corporate decision-making • Demonstrating value of the expensive MSL and Advisor roles to MAIN CONFERENCE · DAY TWO the company 7:00 BREAKFAST FOR CONFERENCE PARTICIPANTS Dr. Samuel Dyer, Former Senior Regional Medical Director, GENENTECH, United States 8:00 Chairperson’s Recap of Day One and Moderators’ Key Points from Roundtable Discussions 11:45 LUNCHEON Dr. Alan Yong, Medical Affairs Manager Oncology, GLAXOSMITHKLINE, United Kingdom 12:45 · CASE STUDY: FORMULARY DISCUSSIONS 8:15 · OFF-LICENCE INFORMATION Supporting Reimbursement Teams in Demonstrating Clinical Value to Payers Compliantly Responding to Unsolicited Questions and Establishing Parameters for Off-Label Discussions • Involving MSLs/Advisors early in the process to best facilitate formulary negotiations • Defining what “off-licence” and “unsolicited request” mean to • Proactively providing scientific information to educate health your company care payers • Discussing benefits versus risks to the franchise when • Improving communication between internal teams for stronger establishing SOPs for off-licence requests value demonstrations • Exploring strategies for handling requests that physicians make • How is the role of the health care payer changing and is there a to sales need for a dedicated sub-speciality of MSLs/Advisors? • Determining what information needs to be included when documenting requests and conversations Becky Reeve, Scientific Advisor Manager, Cardiovascular & • Examining the regulations surrounding off-licence information Metabolism SAMs, SANOFI-AVENTIS, United Kingdom dissemination and considering the penalties and damage to the company of noncompliance 13:30 · CAREER DEVELOPMENT Dr. Nikki Church, Senior Medical Advisor, General Medicine, Identifying Different Opportunities Available to Individuals BAYER, United Kingdom with MSL/Advisor Experience, Education Levels and Skills • Considering different positions within the company and 9:00 · COMPLIANCE AND TECHNOLOGY industry that are aligned with the qualifications of MSLs and Advisors Utilizing Technology to Increase Efficiency, Minimise Risk • Being a champion of your own growth and Manage Compliance Requirements • Engaging in preceptorships, networking events and shadowing activities to refine interests and learn more about different roles • Exploring strategies for how to effectively document off-licence • Determining when the right time is to make a change information requests • Implementing a system for enhanced management and selection Dr. Chris Sugg, Senior Regional Medical Liaison, of KOLs AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States • Gathering and synthesizing field insights and internal communications to benefit both field and office based colleagues 14:15 · PANEL DISCUSSION 9:45 NETWORKING AND REFRESHMENT BREAK How Can Field-Based and Office-Based Medical Affairs Colleagues Best Support Each Other in their Roles? 10:15 · PERFORMANCE EVALUATION • What kinds of field insights are valuable for MSLs to bring back to SAs and MAs? Selecting Qualitative and Quantitative Metrics to • How can brand information acquired internally be Demonstrate the Value of the MSL or Advisor communicated to field based medical to support their activities • Weighing the challenges and benefits of qualitative and with KOLs? quantitative metrics • How can teams ensure meaningful collaboration to support • Discussing specific metrics that have proven results of effectively corporate objectives? assessing performance • Planning ahead for success by setting targets and agreeing on Panelists: performance goals Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Medical • Ensuring that selected metrics are compliant and not tied to direct Centre of Excellence, BRISTOL-MYERS SQUIBB, France sales generated for the company Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global Medical Affairs, UCB PHARMA, Belgium Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Interested in joining this panel discussion? Please contact Lindsay Slater at Medical Centre of Excellence, BRISTOL-MYERS SQUIBB, France lslater@exlpharma.com for more information. 15:00 CLOSE OF CONFERENCE
  5. 5. Sponsorship and Exhibiting Opportunities Do you want to spread the word about your organisation’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact: Lucas Carrasco, business Development manager +1 212-400-6231, lcarrasco@exlpharma.com MeDIA PARtneRS FIVe WAYS to ReGISteR Fax: +1 212-400-9408 Mail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018 Phone: +1 212-400-6240 Online: www.exlpharma.com Email: register@exlpharma.com EARLY BIRD PRICING Register by Friday, 17 September 2010 to Take Advantage of Early-Bird Pricing: Conference + Workshop £1,450 Conference Only £1,300 STANDARD PRICING Register After Friday, 17 September 2010: Conference + Workshop £1,600 Conference Only £1,450 ONSITE PRICING Conference + Workshop £1,750 Conference Only £1,600 GRoUP DISCoUnt PRoGRAM: Save 25% per person when Registering Four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person. Save 15% per person when Registering Three Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call + 1 212-400-6240. Important! Discounts may not be combined. Discount only applies to standard rate. Make checks payable to ExL Events, Inc. and write code P1122 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference. Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event: Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date. Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date. To receive a refund or voucher, please fax your request to +1 212-400-9408. Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference. Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the replacement attendee. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. *The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.* To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl
  6. 6. REGISTER bY 17TH SEPTEMbER FOR REDUcED PRIcING Medical/Scientific Advisor and Medical Science PLEASE MENTION PRIORITY CODE: P1122 Exp. Date: PROUDLY PRESENTS Liaison Best Practices 555 8th Avenue, Suite 310 New York, NY 10018 Bringing Maximum Value to the KOL, Company and Industry 28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON FEATURED SESSIONS INCLUDE: Distinguished Name on Card Speaking Faculty DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SA Card Number Signature Exploring Similarities and Differences in Job Titles, Descriptions and Joins Us From: Daily Activities of Medical Science Liaisons, Medical Advisors, and Scientific Advisors across Companies and Countries AMGEN Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global ARNOLD & PORTER Medical Affairs, UCB PHARMA, BELGIUM BAYER Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom Please contact me: I’m interested in marketing opportunities at this event BRISTOL-MYERS SQUIBB INVESTIGATOR INITIATED TRIALS (IITs) register@exlpharma.com I wish to receive email updates on ExL Pharma’s upcoming events BRITISH PHARMACOPOEIA Outlining Best Practices for How MSLs and Advisors Can Best Support www.exlpharma.com Zip the Successful Execution of IITs across the EU COMMISSION Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom 888-221-6750 FELTER CONSULTING LTD FORMER GENENTECH KEY OPINION LEADER INITIATION AND DEVELOPMENT Yes! Register me for the Main Conference GLAXOSMITHKLINE Effectively Managing Relationships to Meet the Needs and Objectives State Title of the KOL and the Company Fax LILLY Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France PFIZER SANOFI-AVENTIS cAREER DEVELOPMENT Corporate Rate: Main Conference UCB Identifying Different Opportunities Available to Individuals with Corporate Rate: Plus Workshop AND MORE! MSL/Advisor Experience, Education Levels and Skills Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC New York, NY 10018 TO R E G I S T E R AFFAIRS, United States 555 8th Avenue, ExL Events, Inc. and Workshop 866-207-6528 The Only Event Led by, and Designed for, Suite 310 European Pharmaceutical, Biotech and Medical Device Advisors and MSLs! Telephone Company Address Name Email Dept. City To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl

×